REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a pr...
Q2 2026
Aug 6, 2026
Q1 2026
May 14, 2026
FY 2025
Mar 5, 2026
Q4 2025
Q3 2025
Nov 6, 2025